Literature DB >> 9652620

Acarbose-induced hepatic injury.

Y Fujimoto, M Ohhira, N Miyokawa, S Kitamori, Y Kohgo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9652620     DOI: 10.1016/S0140-6736(05)78337-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Practical guidelines for diagnosis and early management of drug-induced liver injury.

Authors:  Kazuto Tajiri; Yukihiro Shimizu
Journal:  World J Gastroenterol       Date:  2008-11-28       Impact factor: 5.742

2.  Fatal liver failure due to reactivation of lamivudine-resistant HBV mutant.

Authors:  Tatehiro Kagawa; Norihito Watanabe; Hisashi Kanouda; Ichiro Takayama; Tadahiko Shiba; Takashi Kanai; Kazuya Kawazoe; Shinji Takashimizu; Nobue Kumaki; Kazuo Shimamura; Shohei Matsuzaki; Tetsuya Mine
Journal:  World J Gastroenterol       Date:  2004-06-01       Impact factor: 5.742

3.  Evaluation of the efficacy and tolerability of miglitol in Chinese patients with type 2 diabetes mellitus inadequately controlled by diet and sulfonylureas.

Authors:  Sheng-Hwu Hsieh; Kuang-Chung Shih; Chien-Wen Chou; Chih-Hsun Chu
Journal:  Acta Diabetol       Date:  2010-10-21       Impact factor: 4.280

4.  Risk of liver injury after α-glucosidase inhibitor therapy in advanced chronic kidney disease patients.

Authors:  Chih-Chin Kao; Pei-Chen Wu; Che-Hsiung Wu; Li-kwang Chen; Hsi-Hsien Chen; Mai-Szu Wu; Vin-Cent Wu
Journal:  Sci Rep       Date:  2016-01-11       Impact factor: 4.379

5.  Development of an antidiabetic formulation (ADJ6) and its inhibitory activity against α-amylase and α-glucosidase.

Authors:  Anand Duraiswamy; Devanand Shanmugasundaram; Changam Sheela Sasikumar; Sanjay M Cherian; Kotturathu Mammen Cherian
Journal:  J Tradit Complement Med       Date:  2015-02-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.